H╬╝REL
North Brunswick, New Jersey, United States
About H╬╝REL
H╬╝REL is an early-stage bioanalytic tools company with operations based in Kenilworth and New Brunswick, New Jersey, USA. Robert Freedman serves as Chief Executive Officer. Martin Yarmush is the Company’s Chief Scientific Adviser.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2013)
- Website: hurelcorp.com
- Phone: +1 310-652-5900
Industries & Categories
Biotechnology, Clinical Trials, Education, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/h-rel-2603978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.